-
-
-
-
-
-
-
NLS Pharmaceutics (NLSP) Reports Positive Results from Study KO-874 on Mazindol’s Neuroprotective Effects in Narcoleptic-like Rat Model
-
-
-
-
-
-
-
Predictive Oncology Inc. (POAI) Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented
-
-
-
-
-
-
-
Elanco Animal Health (ELAN) Announces FDA Has Completed Review of Bovaer
-
-
-
-
-
-
-
Merus (MRUS) Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m HNSCC at the 2024 ASCO Annual Meeting
-
-
-
-
-
-
-
Coherus BioSciences (CHRS) Presents Prelim Results from Phase I Dose Escalation Study of CHS-114
-
-
-
-
-
-
-
Theriva Biologics (TOVX) Announces Fast Track Designation Granted by the U.S. FDA for VCN-01 for the Treatment of Metastatic Pancreatic Cancer
-
-
-
-
-
-
-
NeuroBo Pharmaceuticals' (NRBO) DA-1241 in Combination with Semaglutide Improves Liver Fibrosis and Demonstrates Additive Hepatoprotective Effects in Pre-Clinical MASH Models
-
67,175 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.